Eyenovia Inc. - EYEN Net earnings per one share for the last twelve months

Official company branding of Eyenovia Inc. (EYEN)

Eyenovia, Inc. (EYEN) is creating a closed-loop precision ophthalmology system based on Optejet, earning its status as a leading medical innovator. This annual EPS TTM percentage growth chart illustrates profit dynamics, where the current figure stands at -18.20. Top-tier engineers and physicians are driving the project's development, focusing on the successful completion of clinical trials and the commercialization of unique microdosing products.

EYEN Eyenovia Corp: Net earnings per share (EPS TTM) in the range 02/11/2024 - 02/20/2024
Core merchandise of Eyenovia Inc.

Year-over-year EPS growth (TTM) reflects the annual rate of change in net income per share over the last twelve months for Eyenovia, Inc. (EYEN). The current value of -18.20 demonstrates the efficiency of asset monetization. Stable utilization of ophthalmological production lines directly impacts the calculation base of this indicator. By analyzing the historical trend of year-over-year EPS (over 12 months), an investor assesses the business's resilience to market shocks. Ignoring negative trends in this curve creates a critical risk of capital drawdown.

Competitor analysis

Net earnings per one share for the last twelve months Alcon Inc|BLCO: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Glaukos Medical (GKOS)|Earnings per share for the last twelve months apellis.com|Belite Bio (BLTE) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Ocular Pharma (OCUL)|HROW (Harrow) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) VRDN (Viridian Corp)|LENZ Corp (LENZ) - Net earnings per one share for the last twelve months|OCS: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months eyepointpharma.com|KOD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aldeyra Therapeutics (ALDX)|Net earnings per share for the last 12 months KALA|IRD - Net earnings per share for the trailing year|Earnings per share for the last twelve months okyopharma.com (OKYO)|Net earnings per share (EPS TTM) Adverum Biotechnologies Inc. (ADVM)|Earnings per share for the last twelve months outlooktherapeutics.com OTLK|Net earnings per share for the last four quarters Clearside Biomedical, Inc. (CLSD)|NBY - Earnings per share for the last twelve months|Earnings per share for the trailing year KPRX (kiorapharma.com)|Alimera Sciences (ALIM) - Earnings per share for the last twelve months|Guardion Health Science - Earnings per share for the trailing year|Earnings per share for the last twelve months Ocuphire Pharma, Inc.|Opthea Ltd. (OPT) - Net earnings per share for the last four quarters